Guodong Peng

Guodong Peng

Auto-generated profile, based on publicly available information

Guodong Peng

School of Automation and Electrical Engineering, Inner Mongolia University of Science and Technology, Baotou, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2024
Verified
Conference Paper
Open access
GPGuodong Peng
Guodong Peng
XJXiangmin Ji
Xiangmin Ji
Adverse drug reactions induced by drug-drug interactions are important causes of morbidity and mortality. To address the issues that the existing models ignore the multidirectional mutual semantic transmission and local-global feature interaction in drug pairs, we propose an effective knowledge graph embeddings based on CNN-LSTM for drug-drug interactions prediction (KGECL). This framework consists of four components: data preprocessing module, interaction feature extraction module, attention module and prediction modules. The data preprocessing module conducts low-dimensional embeddings of drug data. The interaction feature extraction module explores multidirectional semantics and local-global characteristics, and simulate the complex relationships and interactions across multiple adverse reactions effectively. The attention module enhances the ability of network to recognize the critical information. Finally, the prediction module uses a fully-connected layer for prediction. Comparative experiments on two available datasets demonstrates that KGECL achieves higher accuracy and helps to the improve drug safety.

9 December 2024 in IEEE Access
Verified
Journal Article
Open access
XLXiang Li
Xiang Li
XJXiangmin Ji
Xiangmin Ji
CXChengzhen Xu
Chengzhen Xu
Jie HouJie Hou
Jie Hou
XZXiaoyu Zhao
Xiaoyu Zhao
GPGuodong Peng
Guodong Peng
Drug–drug interactions (DDIs) can severely affect patient health and safety. Predicting potential DDIs before administering medication to patients is crucial for drug development as it helps to prevent adverse drug reactions. Many effective DDI prediction methods have been proposed using graph neural networks; however, these methods only aggregate information from directly connected nodes restricted to a drug-related manner and fail to capture long-range dependencies in heterogeneous networks. To address this issue, we propose an enhanced multiple-feature hybrid graph method to predict DDIs (MFHG-DDI). Specifically, we constructed a heterogeneous network incorporating multiple drug features and DDI information. We employed an enhanced hybrid graph module that integrates a graph convolutional network, graph attention network, and global average pooling to learn latent features, ultimately applying a prediction function to predict DDIs. MFHG-DDI reframes the heterogeneous network as a graph classification task, capturing DDI information efficiently through an enhanced hybrid graph. Known DDI datasets were used to train and evaluate the proposed model. The experimental results indicate that integrating multiple drug features into the hybrid graph method can enhance the DDI prediction accuracy, increases the success rate of combination therapy, and has the potential to enhance drug safety.